- Bio surgical agents, including hemostats, sealants, and adhesives, are playing an increasingly critical role in modern surgical procedures by enhancing wound closure, minimizing intraoperative blood loss, and promoting faster healing, making them essential in various surgical specialties such as cardiovascular, orthopedic, and general surgery
- The rising demand for bio surgical agents in Asia-Pacific is largely fueled by the region’s growing surgical volume, aging population, and increasing prevalence of chronic conditions requiring surgical intervention, along with growing awareness about advanced wound care practices among healthcare professionals
- China dominated the Asia-Pacific bio surgical agents market with the largest revenue share of 36.1% in 2024, attributed to rapid healthcare infrastructure development, a large patient pool, and strategic expansions by global medical device companies entering the Chinese market with localized manufacturing and distribution partnerships
- India is expected to be the fastest-growing country in the Asia-Pacific bio surgical agents market during the forecast period due to increased healthcare spending, a surge in private hospital investments, and rising medical tourism
- Hemostatic Agent segment dominated the Asia-Pacific bio surgical agents market with a market share of 45.8% in 2024, driven by its rapid effectiveness in controlling bleeding during surgeries and its widespread application across multiple surgical specialties
